RLH
GILD icon

RD Lewis Holdings’s Gilead Sciences GILD Stock Holding History

RD Lewis Holdings’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$229K Buy
1,705
+75
+5% +$9.88K 0.17% 85
2026
Q1 		$232K Sell
1,630
-41
-2% -$5.74K 0.2% 84
2025
Q4 		$239K Hold
1,671
– – 0.2% 79
2025
Q3 		$206K Buy
+1,671
New +$190K 0.19% 81

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RD Lewis Holdings's GILD Position: Q2 2026 in Review

RD Lewis Holdings increased its Gilead Sciences (GILD) stake by 4.6% in Q2 2026, buying an estimated $9.88K and bringing the position to 1,705 shares worth $229K. The position accounts for 0.17% of the portfolio, ranked #85.

RD Lewis Holdings first reported a position in GILD in Q3 2025 and has held it in 4 quarters since. The position peaked at $239K in Q4 2025. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • RD Lewis Holdings held 1,705 shares of Gilead Sciences worth $229K as of Q2 2026.
  • RD Lewis Holdings bought 75 Gilead Sciences shares in Q2 2026, an estimated $9.88K.
  • Gilead Sciences made up 0.17% of RD Lewis Holdings's portfolio in Q2 2026, its #85 holding.
  • RD Lewis Holdings first reported a position in Gilead Sciences in Q3 2025 and has held it in 4 quarters since.
  • RD Lewis Holdings's Gilead Sciences position peaked at $239K in Q4 2025.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on RD Lewis Holdings's 13F filing for Q2 2026, filed 12 Aug 2026.